Drug profile · INN
atorvastatin
APO-ATORVASTATIN
atorvastatin (APO-ATORVASTATIN) is a hmg-coa reductase inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 1
Pipeline programs 41
News articles 0
Drug details — atorvastatin
- Class
- —
- Route
- —
- Patents
- 1
- Programs
- 41
- Data quality
- 0.81
Quick answer
atorvastatin (APO-ATORVASTATIN) is a hmg-coa reductase inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN atorvastatin
Brand APO-ATORVASTATIN
Mechanism HMG-CoA reductase inhibitor
Originator Alphapharm Pty Ltd
Mechanism of action
HMG-CoA reductase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related patents
Frequently asked questions
What is atorvastatin?
atorvastatin (APO-ATORVASTATIN) is a hmg-coa reductase inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for atorvastatin?
APO-ATORVASTATIN is a marketed brand name for atorvastatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.